Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector.
The FDA says there's no evidence that antibacterial soaps do a better job cleaning hands, and chemicals in them may pose health hazards. The FDA ban applies only to consumer products, not those used in hospitals and food service settings.
Mike Kemp/Blend Images/Getty Images
Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions.
Daniel Acker/Bloomberg via Getty Images
In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells.
Sebastien Bozon/AFP/Getty Images